Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > up up

<< Previous

Bullboard Posts

Next >>

Comment by jfm1330on Feb 24, 2021 11:06pm

109 Views

Post# 32655159

RE:RE:up up

They need to sound optimistic about sales of their two approved drugs in the relative short term. THey need to make clear that this is trending positively. I know it's not the flavour of the month here, but it is still a key element at this point for stock valuation.

Wino115 wrote: What are you expecting them to say in order for that to happen? Otherwise, not much has changed except that we all think it's cheap. Just wondering if you have a suspicion or two.

muslix1 wrote:
I expect TH explode tomorrow..
buckel up guys